Wnt signaling regulates several cellular processes, including differentiation,
proliferation, and stem cell pluripotency. Mutations in Wnt signaling are known to lead
to tumor initiation and progression. Wnt/ β-catenin signaling is dysregulated in breast
cancer, where it has been shown to mediate oncogenic progression. In this review, the
canonical and non-canonical pathways of Wnt/ β-catenin signaling, and their regulation
of breast cancer oncogenesis and progression are described. During the last decade,
several small molecules and natural compounds have shown to interfere with Wnt
signaling and demonstrate potential as Wnt-targeting therapeutic agents. This review
also highlights these molecules, some of which are in clinical trials. Finally, strategies
of using these molecules in combination therapies with other drug agents are discussed.
Keywords: β-catenin, Breast cancer, Canonical and Non-canonical pathways,
Mutations, Oncogenesis, Proliferation, Stem cell pluripotency, Wnt signaling.
